Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page’s footer revision indicator is updated from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov software release/version change rather than a change to the trial record itself.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision v3.5.2 was added to the history and Revision v3.5.0 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was deleted.SummaryDifference0.1%

- Check49 days agoChange DetectedThe Record History shows an added revision entry for v3.4.3 and a removed entry for v3.4.2.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.4.2 to the study history. Removed an outdated funding notice and the older Revision: v3.4.1 from the page history.SummaryDifference0.8%

- Check84 days agoChange DetectedSite-wide notices were added about a lapse in government funding and the NIH Clinical Center status, and a new release note (Revision: v3.4.1) was added; the previous release note (Revision: v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.